Ana Tari Ashizawa

Affiliations: 
Neuroscience University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Aging & Memory Loss,Neurodegeneration,Lipid Nanoparticles, Liposome Formulations, Small Molecule Delivery,Oligonucleotide Delivery
Google:
"Ana Ashizawa"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gagliardi M, Ashizawa AT. (2021) The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery. Biomedicines. 9
Ohanian M, Lin TL, Craig M, et al. (2020) A phase II study of BP1001 (liposomal Grb2 antisense oligonucleotide) in patients with hematologic malignancies. Journal of Clinical Oncology. 38
Ashizawa AT, Holt J, Faust K, et al. (2018) Intravenously Administered Novel Liposomes, DCL64, Deliver Oligonucleotides to Cerebellar Purkinje Cells. Cerebellum (London, England)
Ashizawa AT, Ohanian M, Cortes JE. (2016) BP1001, a Novel Therapeutic for Chronic Myelogenous Leukemia Blood. 128: 4239-4239
Ashizawa AT, Cortes J. (2015) Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01. Expert Opinion On Drug Delivery. 12: 1107-20
Holt J, Martuscello R, Deleyrolle L, et al. (2015) Ddel-03Intravenous Nanoparticle Delivery To Glioblastoma Neuro-Oncology. 17
Ashizawa AT, Steindler D. (2014) ET-61 * NOVEL LIPID NANOPARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS TO GLIOBLASTOMA Neuro-Oncology. 16: v92-v92
Lee S, Ashizawa AT, Kim KS, et al. (2013) Liposomes to target peripheral neurons and Schwann cells. Plos One. 8: e78724
See more...